Time-course of depressive symptoms in patients with heart failure

J Psychosom Res. 2013 Mar;74(3):238-43. doi: 10.1016/j.jpsychores.2012.09.019. Epub 2012 Oct 23.

Abstract

Background: It is unclear how depressive symptoms in patients with heart failure develop over time and whether this trajectory of depressive symptoms is associated with hospital admission and prognosis.

Aim: To describe the time-course of depressive symptoms and determine the relationship with hospitalisation and mortality.

Method: Data was analysed using 611 patients with completed CES-D questionnaires at baseline and at 18 months. Data on hospitalisation was collected 18 months after discharge and data on mortality was collected 18 and 36 months post-discharge.

Results: A total of 140 (61%) of the 229 patients with depressive symptoms at discharge had recovered from depressive symptoms after 18 months whereas 71 (18%) of the 382 non-depressed developed depressive symptoms and 89 (39%) of the 229 depressed remained depressed. Patients with recently (i.e. during the last 18 months) developed depressive symptoms showed a significantly higher risk for cardiovascular hospitalisation (HR 1.7, 95% CI 1.1-2.6, P=.016). After 36 months, patients with developed depressive symptoms after discharge were at a higher risk of all-cause mortality (HR 2.0, 95% CI 1.2-3.5, P=.012) and there was a trend towards a higher risk of all-cause mortality in patients with ongoing depressive symptoms (HR 1.7, 95% CI 0.98-3.1, P=.056).

Conclusion: A significant proportion of patients with HF, who were reported depressive symptoms at discharge recovered from depressive symptoms during the following 18 months. However, patients who remained having depressive symptoms or patients who developed depressive symptoms had a worse prognosis.

MeSH terms

  • Aged
  • Comorbidity
  • Depression / epidemiology*
  • Depression / mortality
  • Female
  • Follow-Up Studies
  • Heart Failure / epidemiology*
  • Heart Failure / mortality
  • Heart Failure / psychology
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Time Factors